Senna: Clinical Trials

14 trials of Senna, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 2 terminated, 2 unknown. 6 Not applicable, 3 Phase 4, 2 Phase 2, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 4, Terminated 1, Unknown 1
Phase 43Completed 1, Recruiting 1, Terminated 1
Phase 22Completed 1, Recruiting 1
Early Phase 11Not yet recruiting 1
Phase 11Recruiting 1
Phase 31Unknown 1

Follow Senna: new trials by email Literature Review of Senna trials Research Report on Senna

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Senna vs. Polyethylene Glycol 3350 for the Treatment of Retentive Encopresis in Children
PEG 3350, Senna - Encopresis With Constipation and Overflow Incontinence
Early Phase 1Not yet recruitingShaare Zedek Medical Center802026-07-012026-06-18
PEG3350 vs Senna After Urogyn Surgery
Senna, Polyethylene glycol 3350 - Obstructive Defecation Syndrome, Postoperative Constipation
Phase 4RecruitingSt. Joseph's Health, New York2542025-04-232025-05-28
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
CLENPIQ, MIRALAX, SENNA - Bowel Preparation
Phase 1 / Phase 2RecruitingFerring Pharmaceuticals392022-06-232026-09-04
Bowel Preparation in Elective Pediatric Colorectal Surgery
Senna, Sodium Picosulfate, Magnesium Oxide and Citric Acid, Metronidazole Oral - Colostomy, Hirschsprung Disease - Pull Through
Not applicableUnknownMcMaster University812022-01-012021-12-09
RELISTOR's Effects on Opioid-Induced Constipation
Relistor Injectable Product, Docusate Calcium, Bisacodyl - OIC
WithdrawnMethodist Health System2021-07-012026-03-23
Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation
Current Bowel Protocol (senna/lactulose), PEG Bowel Protocol (PEG/lactulose) - Constipation, Peritoneal Dialysis Complication
Phase 4CompletedNova Scotia Health Authority252017-07-072024-08-21
Gut Transit Effect on Enterohepatic Circulation
Loperamide, Senna - Intestinal Transit
Not applicableCompletedUniversity Hospital Plymouth NHS Trust192017-04-102022-09-30
An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders
Glycerin Suppository, Bisacodyl suppository, Senna - Encopresis, Autistic Disorder
Not applicableCompletedEmory University222015-02-012018-07-02
Efficacy of Linaclotide to Senna for CIC
Senna, Linzess - Chronic Idiopathic Constipation
Not applicableTerminatedTriHealth Inc.92014-09-012019-07-02
A Double-blinded,Double-dummy Clinical Trial of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation
MZRW, Senna, placebo - Functional Constipation, Gastrointestinal Disorders
Phase 2CompletedHong Kong Baptist University2912013-06-012020-05-12
Evaluating the Effect of Senna in Uremic Pruritus
Senna, Placebo - End Stage Renal Disease, Pruritus
Not applicableCompletedShiraz University of Medical Sciences602011-08-012015-04-01
Bowel Preparation for Colonoscopy in Children
polyethylene glycol, senna - Colonoscopy Preparation
Phase 4TerminatedChildren's Hospital of Philadelphia332010-09-012013-04-12
Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation
Lubiprostone, Senna - Constipation
Not applicableCompletedShirley Ryan AbilityLab642008-04-012013-03-06
Bowel Preparation and Prokinetics in Capsule Endoscopy
Senna, Citramag powder, Metoclopramide - Small Bowel Disease, Gastrointestinal Hemorrhage
Phase 3UnknownLondon North West Healthcare NHS Trust1502006-01-012007-09-24

Conditions studied

Constipation (4)  ·  Anemia, Refractory (1)  ·  Autistic Disorder (1)  ·  Behavioral Symptoms (1)  ·  Child Development Disorders, Pervasive (1)  ·  Encopresis (1)  ·  Enterocolitis, Necrotizing (1)  ·  Fecal Incontinence (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Inflammatory Bowel Diseases (1)  ·  Intestinal Obstruction (1)  ·  Kidney Failure, Chronic (1)  ·  Meconium Ileus (1)  ·  Pruritus (1)

Sponsors

Children's Hospital of Philadelphia (1)  ·  Emory University (1)  ·  Ferring Pharmaceuticals (1)  ·  Hong Kong Baptist University (1)  ·  London North West Healthcare NHS Trust (1)  ·  McMaster University (1)  ·  Methodist Health System (1)  ·  Nova Scotia Health Authority (1)  ·  Shaare Zedek Medical Center (1)  ·  Shiraz University of Medical Sciences (1)  ·  Shirley Ryan AbilityLab (1)  ·  St. Joseph's Health, New York (1)  ·  TriHealth Inc. (1)  ·  University Hospital Plymouth NHS Trust (1)

Countries

United States (7)  ·  United Kingdom (2)  ·  Canada (1)  ·  China (1)  ·  Israel (1)

Top investigators

Abdolali Mohagheghzadeh, PhD (1)  ·  Arian Kamali-Sarvestani, Pharm D (1)  ·  Christina M Marciniak, MD (1)  ·  Christopher Fraser, MB BCH, MD, FRCP (1)  ·  Jaclyn Y Tran, BScPharm (1)  ·  Jamshid Roozbeh, MD (1)  ·  Keila S Muniz, MD (1)  ·  Lisa VanHouwelingen, MD, MPH, FRCSC (1)  ·  Mohammad Mehdi Sagheb, MD (1)  ·  Mohd A AlSamman, MD (1)  ·  Petar Mamula, MD (1)  ·  Pouya Faridi, PhD (1)  ·  Richard Meyrat, MD (1)

Results publications

PMID 22699838, PMID 24180235, PMID 25473191, PMID 29654915, PMID 33283264, PMID 38796500